This stock will explode bigtime, Kevetrin completion and a new antibiotic entering phase 3's. Tough waiting, but the waiting will be easy to forget. Not investing deeply one will remember with regret forever. Does IRB meet today and discuss Kevetrin completion? Could that PR show up this week?